Literature DB >> 10417207

Infectivity of Plasmodium berghei sporozoites delivered by intravenous inoculation versus mosquito bite: implications for sporozoite vaccine trials.

J A Vaughan1, L F Scheller, R A Wirtz, A F Azad.   

Abstract

Plasmodium berghei sporozoites delivered by mosquito bite were more infectious to outbred CD-1 mice than were sporozoites delivered by intravenous inoculation. The route of challenge also affected vaccine efficacy. In view of these findings and the fact that mosquito bites are the natural mode of sporozoite delivery, infectious mosquito bites should be considered the challenge protocol of choice for sporozoite vaccine efficacy trials.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417207      PMCID: PMC96740     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

1.  Delayed migration of Plasmodium sporozoites from the mosquito bite site to the blood.

Authors:  S Sidjanski; J P Vanderberg
Journal:  Am J Trop Med Hyg       Date:  1997-10       Impact factor: 2.345

2.  Immunity to Plasmodium berghei exoerythrocytic forms derived from irradiated sporozoites.

Authors:  S Chatterjee; G François; P Druilhe; G Timperman; M Wéry
Journal:  Parasitol Res       Date:  1996       Impact factor: 2.289

3.  Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria.

Authors:  E G Rodrigues; F Zavala; D Eichinger; J M Wilson; M Tsuji
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

4.  Quantitation of Plasmodium falciparum sporozoites transmitted in vitro by experimentally infected Anopheles gambiae and Anopheles stephensi.

Authors:  J C Beier; J R Davis; J A Vaughan; B H Noden; M S Beier
Journal:  Am J Trop Med Hyg       Date:  1991-05       Impact factor: 2.345

5.  Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine.

Authors:  S L Hoffman; M Sedegah; R C Hedstrom
Journal:  Vaccine       Date:  1994-12       Impact factor: 3.641

6.  Interactions of Plasmodium berghei sporozoites and murine Kupffer cells in vitro.

Authors:  M C Seguin; W R Ballou; C A Nacy
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422

7.  Susceptibility of different strains of mice to hepatic infection with Plasmodium berghei.

Authors:  L F Scheller; R A Wirtz; A F Azad
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

8.  Co-localization of inducible-nitric oxide synthase and Plasmodium berghei in hepatocytes from rats immunized with irradiated sporozoites.

Authors:  F W Klotz; L F Scheller; M C Seguin; N Kumar; M A Marletta; S J Green; A F Azad
Journal:  J Immunol       Date:  1995-04-01       Impact factor: 5.422

9.  Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults.

Authors:  D Sturchler; R Berger; C Rudin; M Just; A Saul; C Rzepczyk; G Brown; R Anders; R Coppel; G Woodrow
Journal:  Am J Trop Med Hyg       Date:  1995-10       Impact factor: 2.345

10.  Immunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge.

Authors:  L Rénia; I T Ling; M Marussig; F Miltgen; A A Holder; D Mazier
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

View more
  31 in total

1.  Which routes do Plasmodium sporozoites use for successful infections of vertebrates?

Authors:  A U Krettli; L A Dantas
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Members of the salivary gland surface protein (SGS) family are major immunogenic components of mosquito saliva.

Authors:  Jonas G King; Kenneth D Vernick; Julián F Hillyer
Journal:  J Biol Chem       Date:  2011-09-29       Impact factor: 5.157

3.  Neither mosquito saliva nor immunity to saliva has a detectable effect on the infectivity of Plasmodium sporozoites injected into mice.

Authors:  Chahnaz Kebaier; Tatiana Voza; Jerome Vanderberg
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

Review 4.  Smuggling across the border: how arthropod-borne pathogens evade and exploit the host defense system of the skin.

Authors:  Quentin Bernard; Benoit Jaulhac; Nathalie Boulanger
Journal:  J Invest Dermatol       Date:  2013-12-28       Impact factor: 8.551

5.  Site-dependent recruitment of inflammatory cells determines the effective dose of Leishmania major.

Authors:  Flavia L Ribeiro-Gomes; Eric Henrique Roma; Matheus B H Carneiro; Nicole A Doria; David L Sacks; Nathan C Peters
Journal:  Infect Immun       Date:  2014-04-14       Impact factor: 3.441

Review 6.  Mosquito Saliva Reshapes Alphavirus Infection and Immunopathogenesis.

Authors:  Siew-Wai Fong; R Manjunatha Kini; Lisa F P Ng
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

7.  Anopheles gambiae Lacking AgTRIO Inefficiently Transmits Plasmodium berghei to Mice.

Authors:  Yu-Min Chuang; Marianna Freudzon; Jing Yang; Yuemei Dong; George Dimopoulos; Erol Fikrig
Journal:  Infect Immun       Date:  2019-08-21       Impact factor: 3.441

8.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

9.  Plasmodium yoelii-infected A. stephensi inefficiently transmit malaria compared to intravenous route.

Authors:  Solomon Conteh; Rana Chattopadhyay; Charles Anderson; Stephen L Hoffman
Journal:  PLoS One       Date:  2010-01-28       Impact factor: 3.240

10.  Comparison of Plasmodium berghei challenge models for the evaluation of pre-erythrocytic malaria vaccines and their effect on perceived vaccine efficacy.

Authors:  Wolfgang W Leitner; Elke S Bergmann-Leitner; Evelina Angov
Journal:  Malar J       Date:  2010-05-27       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.